ANGI Form 4: Director Alesia Haas Awarded 16.4K RSUs, No Shares Sold
Rhea-AI Filing Summary
Form 4 snapshot – Angi Inc. (ANGI), filed 06/20/2025: Director Alesia J. Haas reported the grant of 16,436 Restricted Stock Units (RSUs) on 06/17/2025. Each RSU converts into one share of Class A common stock upon settlement.
Key transaction details:
- Transaction code: A (award/grant, no open-market purchase or sale).
- Price: $0 – equity granted as compensation.
- Vesting schedule: Equal annual installments over three years on the anniversary of the 06/17/2025 grant date, contingent on continued service.
- Deferral election: Any vested RSUs will be settled in a lump sum after termination of service.
- Post-transaction beneficial ownership: 16,436 Class A shares held directly through RSUs.
No sales, option exercises, or other derivative activities were reported. The filing therefore reflects routine director compensation rather than a market-driven trade. While the grant modestly increases insider equity alignment, it does not signal a change in corporate outlook or provide new information on Angi’s operational or financial performance.
Positive
- 16,436 RSUs granted to director, modestly increasing insider equity alignment and signaling continued board engagement.
Negative
- None.
Insights
TL;DR: Routine RSU grant to director; neutral impact on valuation.
The 16,436-unit RSU award is standard board compensation. Because there is no purchase or sale and no price discovery, the filing does not alter supply-demand dynamics for ANGI shares. Vesting over three years supports long-term alignment but dilutes shareholders by only ~0.03 % (based on ~55 m shares outstanding), an immaterial level. Absent concurrent sales, the transaction is neutral for investors.
TL;DR: Grant reinforces incentive alignment; governance practices appear standard.
Angi’s use of multi-year RSU vesting ties director interests to sustained performance, consistent with prevalent governance norms. The deferred-settlement election further extends alignment beyond active service. No red-flags—e.g., accelerated vesting or excessive size—are present. Overall, the disclosure is compliant and non-controversial; investor impact is limited.
FAQ
How many RSUs did Angi Inc. (ANGI) grant to Director Alesia J. Haas?
When do the newly granted RSUs to ANGI's director vest?
Was there any sale of Angi Inc. shares in this Form 4?
What is the ownership form of the reported securities?
Does the transaction affect Angi Inc.’s earnings or cash flow?